Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial

This randomized, open-label, multicenter, parallel study imitating real-world clinical practice assessed the effect of switching to weekly teriparatide in patients with glucocorticoid-induced osteoporosis (GIO) with a lumbar spine/proximal femur bone mineral density (BMD) T-score ≤ −2.0 or ≤−1.0 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanki, Toshihiro, Kawazoe, Mai, Uno, Kiyoko, Hirose, Wataru, Dobashi, Hiroaki, Kataoka, Hiroshi, Mimura, Toshihide, Hagino, Hiroshi, Kono, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820936/
https://www.ncbi.nlm.nih.gov/pubmed/36615091
http://dx.doi.org/10.3390/jcm12010292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820936/
https://www.ncbi.nlm.nih.gov/pubmed/36615091
http://dx.doi.org/10.3390/jcm12010292

Ejemplares similares